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Anti-stressExcess or deﬁciency of catecholamine (CA) secretion was related with several diseases. Recently, estrogen and
phytoestrogens were reported to regulate the activity of CA system. Bakuchiol is a phytoestrogen isolated from
the seeds of Psoralea corylifolia L. (Leguminosae) which has been used in Traditional Chinese medicine as a
tonic or aphrodisiac. In the present study, bovine adrenal medullary cells were employed to investigate the
effects and mechanisms of bakuchiol on the regulation of CA secretion. Further, its anti-depressant like and
anti-stress effects were evaluated by using behavioral despair and chronic immobilization stress models. Our
results indicated that bakuchiol showed bidirectional regulation on CA secretion. It stimulated basal CA secretion
in a concentration dependent manner (p b 0.01), while it reduced 300 μM acetylcholine (ACh) (p b 0.01),
100 μM veratridine (Ver) (p b 0.01) and 56 mM K+ (p b 0.05) induced CA secretion, respectively. We also
found that the stimulation of basal CA secretion by bakuchiol may act through estrogen-like effect and the JNK
pathway in an extra-cellular calcium independent manner. Further, bakuchiol elevated tyrosine hydroxylase
Ser40 and Ser31 phosphorylation (p b 0.01) through the PKA and ERK1/2 pathways, respectively. Bakuchiol
inhibited ACh, Ver and 56 mM K+ induced CA secretion was related with reduction of intracellular calcium
rise. In vivo experiments, we found that bakuchiol signiﬁcantly reduced immobilization time in behavioral
despair mouse (p b 0.05 or 0.01), and plasma epinephrine (E) and norepinephrine (NE) levels in chronic immo-
bilization stress (p b 0.05). Overall, these results present a bidirectional regulation of bakuchiol on CA secretion
which indicated that bakuchiol may exert anti-stress and the potential anti-depressant-like effects.
© 2013 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-ND license.Introduction
Catecholamines (CA), which consist of norepinephrine (NE), epi-
nephrine (E) and dopamine (DA), are important neurotransmitters
that mediate various physiological effects. Typically, the “ﬁght or ﬂight
response” induced by acute stress (Cannon and Paz, 1911) is accompa-
nying excess CA secretion of the sympathetic nervous system which
elevates heart rate, blood pressure and blood glucose to help animals
escape from threats. Either excess or deﬁciency of CA secretion disturbs
physiological functions. Therefore, pharmacological agents that alter; E, epinephrine; DA, dopamine;
.
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.Open access under CC BY-NC-ND liceor modify regulation of CA may have potential therapeutic efﬁcacy
for treatments of CA related diseases.
Bovine adrenal medulla cells are derived from multipotent
neural crest cells in the developing embryo. They share a common
sympathoadrenal progenitor with sympathetic neurons. In these
cells, rise of intercellular concentration of Ca2+ is a prerequisite
for secretion and synthesis of CA. Acetylcholine (ACh) induced
Na+ inﬂux by nicotinic ACh receptor-ion channels and veratridine
(Ver) induced Na+ inﬂux by voltage-dependent Na+ channels in-
crease intercellular concentration of Ca2+ by voltage-dependent
Ca2+ channels; high K+ directly gates voltage-dependent Ca2+
channels to increase Ca2+ inﬂux without increasing Na+ inﬂux
(Wada et al., 1985). Because CA secretion mediated by stimulation
of these ion channels in adrenal medullary cells was thought to be
similar to that of norepinephrine (NE) and epinephrine (E) in the
sympathetic neurons, bovine adrenal medullary cells have been
widely used as a sympathetic model (Haass et al., 1997; Matsuda
et al., 2008; Satoh et al., 2012).
Phytoestrogens are plant-derived compounds showing estrogen-
or antiestrogen-like effects (Albertazzi and Purdie, 2002). Recentnse.
Fig. 1. Chemical structure of bakuchiol.
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on CA system. Estrogen receptors have been found in adrenergic neu-
rons, cholinergic neurons and neuroendocrine cells (Haywood et al.,
1999; Milner et al., 2001). Further evidences show that estrogen and
phytoestrogens can regulate synthesis, secretion and degradation
of CA. Estradiol benzoate elevates the mRNA expression of tyrosine
hydroxylase (TH), the rate-limiting enzyme of CA synthesis (Serova
et al., 2002). 17β-estradiol (E2) stimulates CA synthesis via activation
of p44/42MAPK (Yanagihara et al., 2006) and decreases monoamine
oxidase-A activity (Ma et al., 1993, 1995). Phytoestrogen like daidzein
suppresses CA secretion at high concentrations while stimulating CA
synthesis at low concentration (Liu et al., 2007). Resveratrol (3,4′,5-
trihydroxy-trans-stilbene), a natural polyphenolic compound found in
grapes, berries and redwine,was reported to be an agonist for the estro-
gen receptor (Gehmet al., 1997). It suppresses CA secretion and synthe-
sis induced by ACh (Shinohara et al., 2007). Cimicifugoside, a triterpene
glycoside from black cohosh, possesses a steroid backbone structure, so
was called phytoestrogen. It did not affect the KCl-induced secretion but
inhibited a nicotinic ACh receptor (nAChR) agonist 1,1-dimethyl-4-Fig. 2. Bidirectional effects of bakuchiol on CA secretion on bovine adrenal medullary cells. (A)
various secretagogues induced CA secretion. (C) Effects of 100 μMbakuchiol on CA secretion ind
induced by various concentrations of K+. Data were expressed in means ± SD based on threephenylpiperazinium iodide (DMPP) induced CA secretion in bovine
chromafﬁn cells (Woo et al., 2004).
Bakuchiol (the structure was showed in Fig. 1) is a prenylated
phenolic monoterpene isolated from the seeds of Psoralea corylifolia L.
(Leguminosae) which has been broadly used clinically in Traditional
Chinese medicine. Kim KA reported that 10 μM bakuchiol had protec-
tive effects against oxidative stress (Kim et al., 2013). Bakuchiol also
exerts antibacterial (Hsu et al., 2009), anti-inﬂammation (Choi et al.,
2010; Ferrandiz et al., 1996), anti-tumor (Chen et al., 2010; Yang
et al., 2010), immunosuppressive (Chen et al., 2008), and hepatoprotec-
tive effects (Cho et al., 2001; Park et al., 2007) and hypoglycemic activity
(Krenisky et al., 1999). In addition, our group recently reported that
bakuchiol possesses phytoestrogenic activity (Xin et al., 2010) which
explains its effect in reducing bone loss in ovariectomized Sprague–
Dawley rats (Lim et al., 2009). Meanwhile, bakuchiol analogs inhibit
monoamine transporters and regulate monoaminergic functions
(Zhao et al., 2008), suggesting a potential interaction of bakuchiol and
CA. In the present study, we speculated that phytoestrogen bakuchiol
may regulate CA secretion and this action may exert anti-depression
or anti-stress activity. We employed chromafﬁn cells to investigate
the effect of bakuchiol on the regulation of CA secretion. To examine
the in vivo mental effects of bakuchiol, forced swim test (FST), tail
suspension test (TST) and immobilization stress test (IMST) were
employed in mice.Methods
Isolation and primary culture of bovine adrenal medullary cells. Adrenal
glands were obtained from the city slaughterhouse. Bovine chromafﬁn
cells were isolated as described previously (Mao et al., 2009). All
the cells from different bovines (both male and female) were mixed
together before planting. Primary cells between 2 and 7 days of culture
were used for experiments.Effects of 1–100 μM bakuchiol on basal CA secretion; (B) effects of 100 μM bakuchiol on
uced by various concentrations of ACh and (D) effects of 100 μMbakuchiol on CA secretion
independent experiments in triplicate (n = 7–9 per group). *p b 0.05, **p b 0.01.
Fig. 3. Stimulation of bakuchiol on basal CA secretion on cultured bovine adrenal
medullary cells. (A) The cells were treated with or without nitrendipine (10 μM) in
the presence or absence of bakuchiol (100 μM) for 10 min at 37 °C (n = 6 per group).
(B) Cells were incubated with Ca2+ (−) KRP or Ca2+ (+) KRP in the presence or absence
of bakuchiol (100 μM) for 10 min at 37 °C (n = 8 or 9 per group). CAs secreted into the
medium were measured, and expressed as a percentage of the total CAs in the cells.
Data were means ± SD from three independent experiments in triplicate. **p b 0.01,
NS means no signiﬁcance.
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er was used in cell experiments in this study. Its composition is as fol-
lows (in mM): 154 NaCl, 5.6 KCl, 1.1 MgSO4, 2.2 CaCl2, 0.85 NaH2PO4,
2.15 Na2HPO4 and 10 glucose, adjusted to a pH of 7.4. Reagentswere ob-
tained from the following sources: Eagle's minimum essential medium
(MEM) and new born calf serum from Gibco (USA); collagenase from
Nitta Zerachin (Japan); cytosine arabinoside, ACh, Ver, nitrendipine,
U0126, PD98059 and venlafaxine from Sigma (St. Louis, MO, USA);
primary antibodies of phospho-P44/42 MAPK (Erk1/2) (#9101), p44/
42 MAPK (Erk1/2) (#4695), phospho-SAPK/JNK (#9251), SAPK/JNK
(#9252), phospho-tyrosine hydroxylase (Ser 31) (#3370), phospho-
tyrosine hydroxylase (Ser40) (#2791), and tyrosine hydroxylase
(#2792) were from Cell Signaling Technology; lysis buffer (P0013B),
enhanced BCA protein assay kit (P0010) and SDS-PAGE sample loading
buffer (P0015) were from Beyotime Institute of Biotechnology (China);
bakuchiol was isolated from P. corylifolia L. (Leguminosae) and identi-
ﬁed by 1H NMR method in our laboratory. Quantitative analysis of
the test samples by liquid chromatography showed that the purity of
bakuchiol is greater than 97.0%. For in vitro experiments, bakuchiol
was dissolved in 100% dimethyl sulfoxide (DMSO) and then diluted in
a reaction medium (ﬁnal concentration of bakuchiol was between
1 μM to 100 μM) before use with a ﬁnal concentration of DMSO lower
than 0.5%. Different secretagogues and agents were co-administered
with bakuchiol, except when used alone. For in vivo experiments,bakuchiol was dissolved in 0.2% sodium carboxymethyl cellulose at
1 mg/ml, 2 mg/ml and 4 mg/ml stock solutions. Venlafaxine was dis-
solved in 0.2% sodium carboxymethyl cellulose at 0.67 mg/ml as stock
solution. The above stock solutions were administrated at 15 ml/kg
body weight by intragastric (i.g.) route. Appropriate vehicle-treated
groups (0.2% sodium carboxymethyl cellulose) were also assessed
simultaneously.
Detection of CAs secreted by cultured bovine adrenal medullary cells
by HPLC-ECD. To detect the effect of bakuchiol on CA secretion, the
CAs in culture mediumwere detected by HPLC-ECD. Brieﬂy, bovine ad-
renalmedullary cells were bufferedwith oxygenated KRP andwashed 3
times before experiments. After incubation with the indicated agents at
37 °C for 10 min, medium was transferred immediately to a test tube
containing perchloric acid (PCA) (ﬁnal concentration, 0.4 M). NE and
E secreted into themediumwere detected by a high-performance liquid
chromatographic system coupled with an electrochemical detector
(HPLC-ECD). The chromatographic separation system included RP C18
analytical column (5 μm,φ4.6 mm × 250 mm) and an isocratic solvent
system. The ﬂow phase (1 l) contained: 100 ml acetonitrile, 100 μl
triethylamine, 13.6 g KH2PO4, 2.5 g Octanesulfonic acid sodium and
0.036 g EDTA, adjusted pH to 3.3 with H3PO4. The ﬂow rate was
0.6 ml/min, column temperature 30 °C and sample injection volume
10 μl. The detection was obtained using an electrochemical detector
with two channels: one is at 0 mV and the other +300 mV.
Measurement of intracellular Ca2+ mobilization. To examine the ef-
fects of bakuchiol on intracellular Ca2+ concentration induced by differ-
ent secretagogues, cells were seeded into black-walled clear-base 96-
well plates (Greiner, USA) at a density of about 50,000 cells per well
in culturemedia and grown for approximately 24 h in a 37 °C CO2-incu-
bator. The cells were incubated with the Calcium 4 reagent (Molecular
Devices, Sunnyvale, CA, USA) for 60 min in a 37 °C CO2-incubator.
The Calcium 4 reagent-loaded cells were checked on a FlexStation
III (Molecular Devices, Sunnyvale, CA, USA), to monitor ﬂuores-
cence (ex = 485 nm, em = 525 nm) before and after the addition
of bakuchiol (1–100 μM). Bakuchiol was prepared in assay buffer
with ﬁnal DMSO concentration less than 0.5%. Intracellular Ca2+
mobilization was measured as relative ﬂuorescence units (RFU)
and expressed as percentage of RFU at 0 s.
Western blot. The effects of bakuchiol on the activation of MAPK
(ERK, JNK and p38) pathway and TH proteins were tested by Western
blot analysis. After treatment, culture medium was discarded. The
cellswerewashed twicewith ice-cold KRP buffer, and lysed in lysis buff-
er. Protein concentrationwasmeasured using an enhanced BCA protein
assay kit, and equal amounts of protein were mixed with 5× SDS-PAGE
sample loading buffer. Following heating at 95 °C for 5 min, proteins
were subjected to 10% Tris-glycine gel and transferred electrophoreti-
cally to polyvinylidene diﬂuoride membrane (Bio-Rad). Incubation
with primary antibodies (1:1000) was performed overnight at 4 °C
and then with horseradish peroxidase-labeled secondary antibodies
(1:5000) for 1 h at room temperature. Antibody-positive band was
visualized using enhanced chemiluminescence Western blot detection
reagents. The band densities were measured by Quantity One software
using VersaDoc imaging system (Bio-Rad). Data were expressed as a
ratio of phosphorylated proteins to total proteins (phosphorylated-style
plus non-phosphorylated-style).
Animals. Male ICR strain mice with body weight ranging 18–20 g
(Tianjin Laboratory Animal Center, Certiﬁcate number SCKX-2010-
0002) were used. Animals were group-housed under 12 h/12 h light/
dark schedule and had free access to tap water and food. Ambient tem-
perature and relative humidity weremaintained at 24 ± 1 °C tempera-
ture and 55 ± 5% humidity, respectively. Micewere acclimatized to the
lab for 7 days before experiments. Animal experimentswere carried out
Fig. 4. Role of theMAPK pathway in bakuchiol-induced CA secretion on bovine adrenal medullary cells. (A)Western blot of ERK pathway phosphorylation (n = 6 per group) induced by
bakuchiol. (B) Effect of ERK pathway antagonist U0126 on CA secretion induced by bakuchiol (n = 8or 9 per group). (C)Western blot of JNK pathway phosphorylation (n = 6 per group)
induced by bakuchiol. (D) Effect of JNK pathway antagonist SP600125 on CA secretion induced by bakuchiol (n = 8 or 9 per group). *p b 0.05, **p b 0.01, NS means no signiﬁcance.
183H. Mao et al. / Toxicology and Applied Pharmacology 274 (2014) 180–189at 1 h after administration of bakuchiol or vehicle between 9:00 and
15:00. Animal handling procedures performed in this study were in
accordance with NIH Guide for the Care and Use of Laboratory Animals.
The forced swim test (FST). FST was used to test effects of bakuchiol
against acute stress. FSTwas performed following themethod described
previously (Kaster et al., 2007) with minor modiﬁcations. Venlafaxine,
an antidepressant used in clinic,was used in this study as a positive con-
trol. Brieﬂy, mice were divided into the following groups with n = 9 or
10 in each group: vehicle (0.2% sodium carboxymethyl cellulose),
venlafaxine (10 mg/kg of body weight) and bakuchiol (15, 30 or
60 mg/kg of body weight). A glass cylinder, 20 cm in height and
10 cm in diameter, was ﬁlled with 15 cm of water (23–25 °C). Mice
were placed in water for 6 min and subsequently desiccated before
being returned to their cages. The sessionswere videotaped, and scored
by two independent observers to calculate the accumulated immobility
time during the last 4 min. The immobility behavior is deﬁned as
a mouse which does not make any active movements to escape from
the tank and just keeps itself aﬂoat in water.
The tail suspension test (TST). TSTwas another model used to test the
effects of bakuchiol on acute stress. It was performed following the
method of Steru et al. (1985) with minor modiﬁcations. Brieﬂy, mice
were divided into the following groups with n = 9 or 10 animals in
each group: vehicle (0.2% sodiumcarboxymethyl cellulose), venlafaxine
(10 mg/kg of body weight) and bakuchiol (15, 30 or 60 mg/kg of body
weight). Mice were individually suspended by the tail using adhesive
scotch tape on a pole above the ﬂoor and the total duration of immobility
was calculated during a 6-min test. Data collected were expressed
as a mean of total immobility time in the 6 min test.Open-ﬁeld test. Open ﬁeld test was employed to detect the effects of
bakuchiol on locomotor activities. It was performed as described previ-
ously (Brocardo et al., 2008a, 2008b) with minor modiﬁcations. Brieﬂy,
mice were divided into the following groups (n = 8–10 per group):
vehicle (0.2% sodium carboxymethyl cellulose), venlafaxine (10 mg/kg
of body weight) and bakuchiol (15, 30 or 60 mg/kg of body weight).
Each mouse was placed individually into the center of the “open ﬁeld”
apparatus. Numbers of crossing and rearing were measured during
the last 4 min in a 6-min observation period. Experiments were
performed in the dark room and the apparatus was illuminated by a
60 W bulb positioned 1 m above the center of the circle.
Chronic anti-stress test. Chronic anti-stress test was employed to de-
tect the effect of bakuchiol on stress induced CA elevation. It was per-
formed as described previously (Kvetnansky and Mikulaj, 1970) with
some modiﬁcations. Brieﬂy, mice were divided into the following
groups (n = 7–9 per group): vehicle (0.2% sodium carboxymethyl cel-
lulose), stress (0.2% sodium carboxymethyl cellulose and immobiliza-
tion stress) and bakuchiol (15, 30 or 60 mg/kg of body weight and
immobilization stress). Mice were immobilized in prone position in a
tube 3 cm in diameter. The mice were kept immobilized in the tubes
for 1 h/day in 7 consecutive days to induce chronic stress. On the 7th
day after chronic mild stress test, animals were euthanized by decapita-
tion. Blood samples were collected and centrifuged at 3000 ×g for
15 min at 4 °C. The serum samples collected were detected by HPLC-
ECD analysis as described above.
Statistical analysis. Data were presented as mean ± SD. Results of
Western blots aboutMAPKwere assessed using paired t-test. For chronic
stress assessments, Student's t test was used to compare the effects
between stress and control, and then one-way ANOVA followed by
Fig. 5. Estrogenic effect of bakuchiol on CA secretion on bovine adrenal medullary cells. Concentration curve of E2 binding to (A) estrogen receptorα (n = 5 per group) and (B) estrogen
receptor β (n = 5 per group). Concentration curve of bakuchiol binding to (C) estrogen receptor α (n = 5 per group) and (D) estrogen receptor β (n = 5 per group) and (E) effect of
antagonist of estrogen receptor, ICI 182,780(10 μM) on bakuchiol (10 μM) or E2 (1 μM) induced CA secretion for 24 h (n = 4–6 per group). **p b 0.01.
184 H. Mao et al. / Toxicology and Applied Pharmacology 274 (2014) 180–189Dunnett's post hoc testswas conducted to identify differences among the
groups between stress and bakuchiol. Other assessments were analyzed
by using one-way ANOVA followed by Dunnett's post hoc tests. The FST
and TST data were blinded before review. Signiﬁcance level was set
at p b 0.05.
Results
Dual effects of bakuchiol on CA secretion in cultured bovine adrenal
medullary cells
Bovine adrenal medullary cells were treated with different
secretagogues in the presence or absence of 100 μM bakuchiol.
Bakuchiol alone signiﬁcantly stimulated CA secretion (vs. baseline,
p b 0.01). Co-treatment of 100 μM bakuchiol with 300 μM ACh,
100 μMVer or 56 mM K+ for 10 min signiﬁcantly inhibited CA secretion
(p b 0.05 or 0.01) (Fig. 2A). 10 μM and 100 μM bakuchiol stimulated
basal CA secretion (vs. baseline, p b 0.01, Fig. 2B).
100 μM bakuchiol stimulated CA secretion induced by ACh at 3 μM
and 10 μM, compared with 3 μM and 10 μM ACh alone (p b 0.01).
100 μM bakuchiol signiﬁcantly inhibited CA secretion induced by
100 μM and 300 μM ACh (p b 0.01, Fig. 2C). When 5.6 mM, 25.6 mM,
35.6 mM, 45.6 mM and 56 mM K+ were used, 100 μM bakuchiolstimulated CA secretion induced by 5.6 mM K+, while it inhibited
56 mM K+ induced CA secretion (p b 0.05, Fig. 2D).
Stimulation of bakuchiol on basal CA secretion in cultured bovine adrenal
medullary cells
Stimulatory modes of bakuchiol on basal CA secretion in cultured
bovine adrenal medullary cells
The effect of nitrendipine, a Ca2+ channel blocker, on bakuchiol-
induced CA secretionwasmeasured. 10 μMnitrendipine signiﬁcantly at-
tenuated bakuchiol-induced CA secretion compared with bakuchiol
alone (p b 0.01), but there was no signiﬁcant difference between
nitrendipine and nitrendipine plus bakuchiol groups (p = 0.34, Fig. 3A).
We also evaluated that bakuchiol signiﬁcantly stimulated the
basal CA secretion in the presence or absence of extracellular Ca2+
(p b 0.01, Fig. 3B).
The role of MAPK pathway activation in bakuchiol-induced catecholamine
secretion
Results of Western blot showed that 100 μM bakuchiol alone signif-
icantly promoted the p44/42 ERK pathway phosphorylation (Student's t
test, p = 0.009, Fig. 4A). 100 μMU0126, an antagonist of the ERK path-
way, stimulated CA secretion induced by 100 μM bakuchiol (p b 0.01,
Fig. 6. Effects of bakuchiol on the phosphorylation of tyrosine hydroxylase on bovine adrenal medullary cells. (A) Time course of TH Ser31 phosphorylation (n = 9 per group) induced
by 100 μM bakuchiol. (B) Effect of ERK pathway on phosphorylation of TH Ser31 (n = 6 or 7 per group) induced by 100 μM bakuchiol. (C) Time course of TH Ser40 phosphorylation
(n = 9 per group) induced by 100 μM bakuchiol. (D) Effect of PKA pathway on phosphorylation of TH Ser40 (n = 7 per group) induced by 100 μM bakuchiol. **p b 0.01.
185H. Mao et al. / Toxicology and Applied Pharmacology 274 (2014) 180–189Fig. 4B). PD98059, another antagonist of ERK pathway, had the same
effect as with U0126 (data not shown).
100 μM bakuchiol alone also signiﬁcantly promoted the
phosphorylation of the JNK pathway (Student's t test, p = 0.02,
Fig. 4C). SP600125 (100 μM), an antagonist for the JNK pathway,
signiﬁcantly inhibited 100 μM bakuchiol induced CA secretion
(p b 0.05) while there was no signiﬁcant difference between SP600125
and SP600125 plus bakuchiol groups (p = 0.09, Fig. 4D). However,
we found that bakuchiol did not affect the phosphorylation of the p38
pathway (data not shown).
Bakuchiol stimulated CA secretion through estrogenic effect
Fluorescence polarization method was used to investigate the afﬁn-
ity of E2 and bakuchiol on ERα and ERβ. The IC50 of E2 for ERα and ERβ
was 6.60 nM and 13.60 nM (Figs. 5A and B), respectively. The IC50 of
bakuchiol for ERα and ERβ was 241.00 nM and 3.52 nM (Figs. 5C
and D), respectively. When ICI 182,780 (10 μM), an antagonist of estro-
gen receptor, were incubated with bakuchiol (10 μM) or E2 (1 μM) for
24 h, CA secretion induced by bakuchiol was signiﬁcantly decreased
(p b 0.01, Fig. 5E).
Effect of bakuchiol on the phosphorylation of tyrosine hydroxylase in
bovine adrenal medullary cells
Western blot assay showed that after incubation with 100 μM
bakuchiol for 0–60 min, non-phosphorylated-tyrosine hydroxylase pro-
tein expression was not changed. Similar result was also observed when
the cellswere incubatedwith 10 μMbakuchiol for 24 h (data not shown).
TH Ser31 phosphorylation induced by100 μM bakuchiol was time
sensitive. The level of TH Ser31 phosphorylation peaked at 30 min(p b 0.01, Fig. 6A), subsequently decreased after 60 min. 100 μM
bakuchiol signiﬁcantly stimulated catecholamine secretion (vs.
baseline, p b 0.01, Fig. 6B), while incubation with 100 μM bakuchiol
and 10 μM PD98059, an antagonist of the ERK pathway, for 30 min,
signiﬁcantly attenuated phosphorylation of TH Ser31 (vs. bakuchiol,
p b 0.01).
TH Ser40 phosphorylation was also promoted and peaked at
30 min (p b 0.01, Fig. 6C) by 100 μM bakuchiol which also sig-
niﬁcantly stimulated CA secretion (vs. baseline, p b 0.01, Fig. 6D).
H89 (10 μM), a PKA pathway antagonist, signiﬁcantly reduced
phosphorylation of TH Ser40 (p b 0.01) induced by 100 μM
bakuchiol.Inhibition of bakuchiol on CA secretion and the elevation of [Ca2+]i induced
by various secretagogues in bovine adrenal medullary cells
In order to characterize the inhibition of bakuchiol on nAChR-ion
channels, voltage-dependent Na+ channels, and voltage-dependent
Ca2+ channels, we studied the effects of 1–100 μM bakuchiol on CA se-
cretion and increase [Ca2+]i induced by ACh, Ver and 56 mM K+.
Incubation of bakuchiol (1–100 μM) for 10 min signiﬁcantly reduced
ACh (p b 0.01, Fig. 7A), Ver (p b 0.05 or 0.01, Fig. 7C) and 56 mM K+
(p b 0.05 or 0.01, Fig. 7E) induced secretion compared to various secre-
tagogues alone. By detecting the intracellular calcium ion concentration,
we found that bakuchiol (1–100 μM) suppressed [Ca2+]i the increase
induced by ACh (Fig. 7B), Ver (Fig. 7D) and 56 mM K+ (Fig. 7F) in a
concentration dependent manner, which coincides with the results
of CA secretion.
Fig. 7. Inhibition of bakuchiol in CA secretion and the elevation of [Ca2+]i induced by various secretagogues on bovine adrenal medullary cells. Effects of bakuchiol on ACh-induced
CA secretion (A) and [Ca2+]i (B). Effects of bakuchiol on Ver-induced CA secretion (C) and [Ca2+]i (D). Effects of bakuchiol on 56 mM K+-induced CA secretion (E) and [Ca2+]i
(F) (n = 8 or 9 per group). *p b 0.05, **p b 0.01.
186 H. Mao et al. / Toxicology and Applied Pharmacology 274 (2014) 180–189Effects of bakuchiol against acute stress by FST and TST
We demonstrated in the open ﬁeld test that bakuchiol at the dose of
15 mg/kg to 60 mg/kg did not affect the numbers of crossing (p N 0.05,
Fig. 8A) and rearing (p N 0.05, Fig. 8B). Results of TST show that
10 mg/kg venlafaxine, and 30 mg/kg and 60 mg/kg bakuchiol signiﬁ-
cantly declined immobility time compared with the vehicle group
(p b 0.01 or 0.05, Fig. 8C). FST results showed that 10 mg/kg venlafaxine
and 30 mg/kg bakuchiol signiﬁcantly declined immobility time com-
pared with the vehicle group (p b 0.01 or 0.05, Fig. 8D).
Effects of bakuchiol on chronic stress
Seven-day stress induced a signiﬁcant increase of plasma norepi-
nephrine (p b 0.05, Fig. 9A) and epinephrine (p b 0.05, Fig. 9B) com-
pared to the control group. Treatments with 30 mg/kg and 60 mg/kg
bakuchiol signiﬁcantly attenuated plasma norepinephrine induced by
stress (p b 0.05). Bakuchiol at 60 mg/kg signiﬁcantly attenuated plasma
epinephrine induced by stress on the 7th day (p b 0.05).
Discussion
In the present study, we demonstrated that bakuchiol had a dual
effect on CA secretion in cultured bovine adrenal medullary cells.
It inhibited CA secretion induced by various secretagogues, while itsigniﬁcantly stimulated the basal CA secretion when it was used alone
(Fig. 2). To the best of our knowledge, this is the ﬁrst direct evidence
showing the dual effects of bakuchiol on CA secretion.
Although, the exact mechanisms are still unknown, the rise in cellu-
lar Ca2+ concentration is a prerequisite for the synthesis and secretion
of CA. Ca2+ concentration in the cells is affected by Ca2+ channels in
the cell membrane and/or intracellular calcium pools (Stauderman
et al., 1990). 10 μM nitrendipine, a Ca2+ channel blocker, decreased
100 μM bakuchiol-induced CA secretion, indicating that the effect is
mediated by activating the membrane Ca2+ channels in the cell mem-
brane. 100 μMbakuchiol signiﬁcantly stimulating the basal CA secretion
in calcium free medium means that bakuchiol also recruit Ca2+ from
calcium pools inside of the cells to stimulate CA secretion.
Activation of MAPK pathway is involved in stress-induced CA secre-
tion and synthesis (Cortez et al., 2012; Sekine et al., 2011; Wang et al.,
2010). ERK1/2, SAPK/JNK, p38 MAPK are members of the MAPK family.
Bakuchiol promotes the phosphorylation of ERK1/2 and SAPK/JNK path-
ways but had no effect on the phosphorylation of p38 MAPK pathway.
Interestingly, only SAPK/JNK pathway antagonist, SP600125, inhibited
bakuchiol induced CA secretion. Instead of inhibiting CA secretion, the
ERK1/2 pathway antagonist U0126 further stimulated the CA secretion
induced by bakuchiol. We got the same results by using another antag-
onist of ERK1/2 pathway PD98059 (data not shown). Although more
detailedmechanisms remain to be revealed, our work shows that selec-
tive activation of SAPK/JNK pathway by bakuchiol is at least in part
Fig. 8. Anti-depressant like effects of bakuchiol in mouse. (A) Effect of bakuchiol on crossing (A) and rearing (B) (n = 8–10 per group) in open ﬁeld test. (C) Effect of bakuchiol on the
immobility in TST (n = 9 or 10 per group). (D) Effect of bakuchiol on the immobility in FST (n = 9 or 10 per group). *p b 0.05, **p b 0.01, compared with control.
187H. Mao et al. / Toxicology and Applied Pharmacology 274 (2014) 180–189involved in the stimulation of CA secretion from bovine adrenal
medullary cells.
Our ﬂuorescence polarization assay of receptor binding showed that
bakuchiol has a strong afﬁnity for ER, especially for ERβ. Despite the
discrepancy on the selective afﬁnity for ER subfamilies between our
and Lim et al.'s (2011) results, both works conﬁrmed that bakuchiol
had a phytoestrogen-like effect as we have reported previously that
bakuchiol had strongly activated transcription of both ERα and ERβ,
especially on ERβ (Xin et al., 2010). It coincidedwith the binding afﬁnities
of bakuchiol showed in the present work.Fig. 9. Role of bakuchiol against chronic immobilization stress in mouse. (A) Effect
of bakuchiol on NE secretion in serum (n = 7–9 per group). (B) Effect of bakuchiol on E
secretion in serum (n = 7–9 per group). *p b 0.05.Activation of TH, a rate-limiting enzyme in CA synthesis, by phos-
phorylation is the primary mechanism responsible for the maintenance
of CA levels in tissues. The activity of TH can be regulated by phosphor-
ylation at several serine (Ser) residues: Ser 8, Ser19, Ser31, and Ser40 in
the NH2-terminal domain. The phosphorylation of TH at Ser40 and Ser
31, but not at Ser19 or Ser8, can directly increase TH activity. However,
phosphorylation of TH at Ser31 increases the activity of TH to a much
lesser extent than that at Ser40. Phosphorylation at Ser19 increases
the rate of Ser40 phosphorylation leading to an increase in enzyme
activity (Dunkley et al., 2004). Our results suggest that bakuchiol
might increase CA secretion by stimulating CA synthesis through the
activation of TH at sites Ser31 and Ser40.
Recently, accumulated studies reported that estrogen and phytoes-
trogen regulated the CA system by various manners and mechanisms.
Lopez et al. (1991) reported that 17α-estradiol inhibited CA secretion
induced by DMPP, methacholine and 120 mM K+. The Ca2+ uptake
into cells in cultures stimulated by DMPP or high K+ was almost
inhibited completely by 100 μM 17α-estradiol. Yanagihara et al.
(2006) reported that 17β-estradiol (E2) (0.3–100 nM) stimulated CA
synthesis from tyrosine by the activation of tyrosine hydroxylase. The
same results were seen in phytoestrogens such as daidzein (0.01–
1.0 μM), a soy isoﬂavone, and resveratrol (0.1–1.0 μM), a grape poly-
phenol which stimulated CA synthesis (Liu et al., 2007; Shinohara
et al., 2007). However, 17β-estradiol (E2) (Kim et al., 2000), daidzein
and resveratrol at high concentrations (≥1.0 μM) inhibited catechol-
amine secretion induced by various secretagogues such as ACh, Ver
and 56 mM K+. Another phytoestrogen cimicifugoside did not affect
the KCl-induced secretion but markedly inhibited the DMPP-induced
CA secretion in bovine chromafﬁn cells (Woo et al., 2004). Nonylphenol
(NP) is a compound with estrogenic activities and has showed a similar
effect on CA secretion like bakuchiol. NP alone elevated the basal secre-
tion of CA in a dose-dependent manner and NP partially suppressed
DMPP induced CA release (Liu et al., 2008). Butyl benzyl phthalate
(BBP), a plasticizer and an environmental pollutant, exerts genomic
estrogenic-like effects via estrogen receptors. It inhibited the DMPP-
induced secretion of CA in a dose-dependent manner (IC50 measured
as 5 and 6 mM, respectively) (Liu et al., 2003). We ﬁrstly found that
188 H. Mao et al. / Toxicology and Applied Pharmacology 274 (2014) 180–189stimulation of bakuchiol on basal CA secretion may be related with its
phytoestrogenic-like effect.
Although CAs are known to be neurotransmitters in the regulation of
normal functions in healthy humans, CA deﬁciency can also lead to
various diseases such as mental depression (Getachew et al., 2010),
memory loss (Gibbs et al., 2010), Parkinson's disease (Kita and Kita,
2011) and Alzheimer disease (Liu et al., 2011; Yu et al., 2011). In these
diseases, depression is also related with the changes of estrogen levels.
Ovariectomized rats encountered an augmented amount of depressive
behavior (Al-Rahbi et al., 2013). Women were at a higher risk than
men to developmood disorders and depression. The increased risk is as-
sociated with ﬂuctuating estrogen levels that occur during menopausal
transition, a time characterized by drastic ﬂuctuations in estrogen levels
(Wharton et al., 2012). Based on the in vitro ﬁndings, we hypothesized
that phytoestrogen bakuchiol might be beneﬁcial in the treatment of
depression. So TST and FST were employed to check our hypothesis.
Venlafaxine, selected as the positive control in the present study, is
one of the most widely used clinical antidepressant. Compared with
the control group, 30 mg/kg and 60 mg/kg bakuchiol reduced the
immobility time in the TST in a concentration dependent manner
(p b 0.01 or 0.05), and 30 mg/kg bakuchiol also signiﬁcantly reduced
the immobility time in the FST (p b 0.05). Although it is not signiﬁcant,
60 mg/kg bakuchiol also showed a tendency which can reduce the im-
mobility time. These suggest that bakuchiol may possess the potential
antidepressant like effect but further experiments of bakuchiol should
not be more than 60 mg/kg. Since TST and FST were two simple tests
for screening, the antidepressant like effect of bakuchiol and the exact
mechanisms remain to be studied. There were no differences in cross-
ings and rearing between the control group and bakuchiol treated
groups in the open ﬁlled test (OFT). It means that there is no association
of the immobility time in the FST and TST with the alterations in loco-
motor activity. FST and TST results are consistent with the ﬁndings
in vitro and suggest that bakuchiol might be a potential candidate for
the treatment of depression.
It was reported that antidepressant medication with estrogen
replacement therapy (ERT) may speed the onset or augment the
response of antidepressant action (Rasgon et al., 2007). In a recent
study, the inﬂuence of the ERT on the antidepressant response to sertra-
line (50–150mg) in 127 women over 60 years old was evaluated. It
found that women receiving ERT had signiﬁcantly greater improvement
and quality of life than those not receiving ERT (Schneider et al., 2011).
Ourwork suggested that bakuchiol as a phytoestrogenmay augment the
antidepressive effects of classical selective serotonin reuptake inhibitors
(SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs) when
co-administrated. Further studies are required to prove this possibility.
As a kind of neurotransmitter in the regulation of normal functions
in healthy humans, deﬁciency of CA can be harmful. However, over ex-
citation of the CA system caused by long-term stress is also thought to
contribute to the involvement and the exacerbation of hypertension,
coronary heart disease, heart failure (Esler and Kaye, 2000; Esler et al.,
2008), gastric ulcers (Veenstra et al., 2007) and diabetes (Peschke
et al., 2011), meanwhile it can promote aging, tumorigenesis, neuropsy-
chiatric conditions andmiscarriages by DNA damage (Hara et al., 2011).
Our experiments by using a daily immobilization stress model showed
that phytoestrogen bakuchiol signiﬁcantly reduced stress induced
raise of serum CA level. Recently, more and more experimental
data and epidemiological studies reported that estrogen may play an
important role in avoiding cardiovascular diseases (Maulik et al.,
2012; Pedram et al., 2013). Our result was consistent with the report
that the protection of cardiovascular system by estrogenmay be related
to the reduction of CA overﬂow (Fukumoto et al., 2012). The results are
consistent with the ﬁndings in bovine adrenal medullary cells and sug-
gest that bakuchiol might be beneﬁcial for the treatment of stress.
In summary, the present study established that bakuchiol stimulated
basal CA secretion by the JNK pathway through its phytoestrogenic ac-
tivity, while inhibiting CA secretion induced by various secretagogues.This alluded to the fact that bakuchiol may exert different effects on
CA secretion. The study also gives some hints for the potential clinical
use of bakuchiol in the treatment of depression and stress related
disorders.
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